- | Country : -
- | organs : -
- | Specialty : -
Extract
To compare the proportion of patients with PSA response (PSA decrease of 50% from baseline, confirmed three weeks later) of three different repeat dose regimens of Alpharadin in patients with hormone refractory prostate cancer and skeletal metastases.
Inclusion criteria
- Hormone refractory prostate cancer and skeletal metastases